Falu Hospital
10
2
4
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
10%
1 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI
Role: collaborator
Virtual Versus Dye-based Chromoendoscopy in Inflammatory Bowel Disease Surveillance Colonoscopy
Role: collaborator
Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma
Role: collaborator
The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting
Role: collaborator
Effects of a Healthy Nordic Diet on Atherosclerosis in Patients with Coronary Heart Disease
Role: collaborator
Bypass Equipoise Sleeve Trial (BEST)
Role: collaborator
Convalescent Plasma for Treatment of COVID-19
Role: collaborator
Colposcopic Impression in a Birth Cohort Previously Eligible for HPV-vaccination
Role: lead
Feasibility of Sending a Direct Send HPV Self-sampling Kit to Long-term Screening Non-attenders
Role: lead
Vacuum Assisted Wound Closure (VAWC) and Mesh Mediated Fascial Traction
Role: collaborator
All 10 trials loaded